LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Content-transfer-encoding:
7bit
Sender:
Lactation Information and Discussion <[log in to unmask]>
Subject:
From:
Laureen Lawlor-Smith <[log in to unmask]>
Date:
Wed, 10 Jun 1998 19:19:13 +0930
MIME-version:
1.0
Content-type:
text/plain; charset=ISO-8859-1
Reply-To:
Lactation Information and Discussion <[log in to unmask]>
Parts/Attachments:
text/plain (12 lines)
Annelies,
Moclobemide is a well used drug in Australia. It is not mentioned in Hale,
I presume because it is not marketed in the USA. It is used in Australia in
post-partum breastfeeding women. It is the subject of a large trial here
for postnatal depression. Less than 1% appears in the breastmilk and it is
not thought to be hazardous to the breastfeeding infant. The reference is
Pons G, Schoerlin MP, Tam YK et al. Moclobemide excretion in Human Milk.
British Journal of Clinical Pharmacology,1990;29, No 1:27-31.
Laureen Lawlor-Smith
General Practitioner, Lactation Consultant
South Australia

ATOM RSS1 RSS2